A statistical comparison of patients with positive and negative cytology results for tumor cells yielded no significant differences between the two groups in terms of gender, age, distant metastasis or intraperitoneal spread, history of neoadjuvant therapy, and levels of CEA and CA 19-9 markers in both serum and peritoneal lavage. This evidence concerns the gene CEACAM5 and neoplasm.